Smarter dosing for young transplant patients aims to prevent clots
NCT ID NCT05672550
First seen Nov 20, 2025 · Last updated Jun 16, 2026 · Updated 25 times
Summary
This study tested a new way to dose the blood thinner enoxaparin in 50 children who had a kidney transplant. The goal was to prevent dangerous blood clots in the new kidney while avoiding bleeding. The method used a computer model to personalize each child's dose, aiming to keep anti-clotting levels in a safe range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Félix Guyon
La Réunion, France
-
Hôpital Mère Enfant
Lyon, France
-
Hôpital Necker - Enfants malades
Paris, Île-de-France Region, 75015, France
-
Hôpital Necker Enfants Malades
Paris, 75015, France
-
Hôpital Pellegrin
Bordeaux, 33000, France
-
Hôpital Robert Debré
Paris, 75019, France
-
Hôpital de Hautepierre
Strasbourg, France
-
Hôpital de la Villeneuve
Montpellier, France
-
Hôpital des Enfants
Toulouse, France
-
Hôtel Dieu
Nantes, France
Conditions
Explore the condition pages connected to this study.